Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mealtime inhaled insulin lowers fasting glucose: a look at possible explanations.

× No keyword cloud information.

11 in total

Review 1. Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial--mechanisms and implications.

Authors: J Hans DeVries; Frank J Snoek; Piet J Kostense; Robert J Heine
Journal: Diabetes Metab Res Rev Date: 2003 Sep-Oct Impact factor: 4.876

2. Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.

Authors: A Siebenhofer; J Plank; A Berghold; K Horvath; P T Sawicki; P Beck; T R Pieber
Journal: Diabetologia Date: 2004-11-25 Impact factor: 10.122

3. Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs.

Authors: Dale S Edgerton; Doss W Neal; Melanie Scott; Larry Bowen; Warren Wilson; Charles H Hobbs; Chet Leach; Shantha Sivakumaran; Thomas R Strack; Alan D Cherrington
Journal: Diabetes Date: 2005-04 Impact factor: 9.461

4. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

Authors: Teresa Quattrin; André Bélanger; Nancy J V Bohannon; Sherwyn L Schwartz
Journal: Diabetes Care Date: 2004-11 Impact factor: 19.112

5. Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin.

Authors: Klaus Rave; Susanne Bott; Lutz Heinemann; Sue Sha; Reinhard H A Becker; Susan A Willavize; Tim Heise
Journal: Diabetes Care Date: 2005-05 Impact factor: 19.112

6. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.

Authors: S Edwin Fineberg; Tom Kawabata; Deborah Finco-Kent; Cameron Liu; Alan Krasner
Journal: J Clin Endocrinol Metab Date: 2005-03-01 Impact factor: 5.958

7. Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems.

Authors: C L Olsen; E Chan; D S Turner; M Iravani; M Nagy; J L Selam; N D Wong; K Waxman; M A Charles
Journal: Diabetes Care Date: 1994-03 Impact factor: 19.112

8. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.

Authors: Kjeld Hermansen; Tapani Rönnemaa; Astrid Heide Petersen; Shannon Bellaire; Ulf Adamson
Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112

Mealtime inhaled insulin lowers fasting glucose: a look at possible explanations.